• Home
  • About Us
  • Contact Us
  • Submit Press Release
  • Sitemap
Africa News Wire
  • General
  • Business Affairs
  • Lifestyle
  • Health Care
  • Sports
  • Legal
  • Study
  • National
  • Press Releases
  • Home
  • General
  • South Africa: Scientists Explore HIV Vaccine

South Africa: Scientists Explore HIV Vaccine

WebDesk
March 3, 2014 No Comments

A method for developing antibodies with the ability to kill multiple strains of the human immunodeficiency virus (HIV) was announced on Monday by South African scientists working with US researchers.

A small number of HIV-infected people developed the antibodies, but are not helped by them because they are unable to kill the wide range of HIV, said National Institute of Communicable Diseases virology head Prof Lynn Morris.

“We need to understand how to make better antibodies to HIV. We can learn that from people who are already infected, because a small proportion of them [infected people] make these broadly neutralising antibodies,” she told reporters in Johannesburg.

“There has been a lot of focus on the individuals that make this special type of antibodies. That information, we hope, is going to help us make a better vaccine to HIV.”

A KwaZulu-Natal woman, identified in the research as CAP256, had responded to HIV infection by making the broadly neutralising antibodies.

The research team had identified these antibodies in her blood and duplicated them by cloning them in a laboratory.

The cloned antibodies were then used in a series of experiments to clarify the pathway followed by CAP256’s immune system to make the HIV-combating antibodies.

The identification and successful cloning of the antibodies had enabled researchers to make large quantities for further testing, similar to the way a medicine used to prevent or treat HIV would be tested.

“What we have to do now is to design a vaccine that is able to engage with the rare B-cells. If we are able to do that, we should be able to make a vaccine that will take months for people to develop the immunity against HIV,” said Morris.

Sometimes referred to as the body’s army, antibodies are specialised cells produced by B-cells as a primary immune defence. They are used by the body for either treatment or prevention.

Morris said CAP256’s antibodies would be used in a sequence of pre-clinical trials in monkeys, a process which could take years to prove their efficacy.

If successful, the research would guide HIV vaccine development. The antibodies might also be used as treatment for HIV.

The research was primarily funded by the US vaccine research centre, and the science and technology department.

The scientists worked in the “Caprisa” consortium of Aids researchers, which included the University of KwaZulu-Natal, the University of the Witwatersrand, the National Institute of Communicable Diseases, the University of Cape Town, and Columbia University in the US.

Post navigation

Southern Africa: SADC Must Engage Men for Gender Equality
Last Updated: 2014-03-03 Share on facebookShare on twitterShare on emailShare on printMore Sharing Services 0 Decrease Font Size Increase Font Size

Related Articles

Uganda Court Orders Opposition Leader Released from House Arrest

- General
January 25, 2021January 26, 2021

Turkey: No Word from Pirates Who Seized Sailors off Nigeria

- General
January 25, 2021January 26, 2021

Eulogy by the Deputy President, His Excellency David Mabuza, at the virtual memorial service for the late Minister in The Presidency, Mr Jackson Mphikwa Mthembu

- General
January 25, 2021January 26, 2021

News Search

Page Links

  • Home
  • About Us
  • Contact Us
  • Submit Press Release
  • Sitemap

Advertisement

MonthlyArchives

Advertisement

News Archives

January 2021
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Dec    
© Copyright 2021 - Africa News Wire. All Rights Reserved
  • Home
  • About Us
  • Contact Us
  • Submit Press Release
  • Sitemap